Patents Examined by Manuel Mendez
-
Patent number: 11986294Abstract: An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.Type: GrantFiled: May 30, 2023Date of Patent: May 21, 2024Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATIONInventors: Boris P. Kovatchev, Marc D. Breton, Stephen D. Patek
-
Patent number: 11986632Abstract: A system and method for operating an analgesia administration system is disclosed. A control device is associated with a drug delivery device and configured to receive a first user input including at least a portion of a fingerprint of a patient, together with a second user input corresponding to a request to administer medication. The portion of the fingerprint is compared with previously-stored fingerprints to determine an identity of the patient and, in response to receiving the second user input and determining that the patient is an authorized user, one or more sensors are used to obtain one or more signals indicative of a state of the patient. If the state of the patient satisfies a set of medication delivery criteria, the drug delivery device is caused to administer a predefined amount of medication to the patient.Type: GrantFiled: May 13, 2021Date of Patent: May 21, 2024Assignee: CareFusion 303, Inc.Inventors: Brendan John Burgess, Edward Stephen Ferner, Beth A. Schneider, Shannon John Johnson, Daniel M. Abal
-
Patent number: 11986611Abstract: A needle-injection catheter includes a catheter body having a distal end, a proximal end, a stiff proximal portion, a flexible distal portion, and a delivery lumen extending therethrough. In a first embodiment, a straight injection needle extends coaxially from a distal tip of the flexible portion of the catheter body, and a plurality of penetration limiting elements positioned circumferentially about a base of the straight injection needle and configured to fold radially inwardly against a shaft of the needle when constrained in a tubular lumen and to extend radially outwardly when unconstrained. In a second embodiment, a helical needle extends from the distal tip of the flexible portion of the catheter body. The helical needle has at least one helical delivery lumen connected to receive an injectable substance from the delivery lumen of the catheter body.Type: GrantFiled: September 2, 2020Date of Patent: May 21, 2024Assignee: BioCardia, Inc.Inventors: Wai Hsueh, Olin Jay Palmer, Scott Comiso, James B. Ross, Ken Vien, Julio Argentieri, Peter Altman
-
Patent number: 11986625Abstract: In some aspects, systems, devices, and techniques for programming a medical fluid delivery device are described. In one example, the disclosure relates to a system including a medical fluid delivery device configured to deliver a therapeutic agent to a patient, and a processor. The processor may be configured to receive a proposed therapy dosing program that defines a fluid therapy for delivery to a patient via a medical fluid delivery device for a first period of time, determine a total dosage over a second period of time, where the second period of time at least partially overlaps the first period of time, and compare the total dosage over the second period of time to a reference dosage.Type: GrantFiled: July 20, 2020Date of Patent: May 21, 2024Assignee: Medtronic, Inc.Inventor: Touby A. Drew
-
Patent number: 11986417Abstract: The present invention relates to a method of replenishing a system for injecting a substance into the patient's body, when the system is implanted in the patient's body. The method involves replenishing the implanted reservoir by a replenishing needle penetrating the patient's skin and injecting infusion liquid comprising the substance through the replenishing needle directly or indirectly into the reservoir.Type: GrantFiled: February 11, 2021Date of Patent: May 21, 2024Inventor: Peter Forsell
-
Patent number: 11980728Abstract: A radiopaque balloon with a composite wall having a radiopaque adhesive affixing inner and outer layers of the balloon. The radiopaque adhesive provides a radiographic image of the balloon wall with or without the use of radiopaque contract media to inflate the balloon. A radiographically fainter image is provided as the balloon is inflated with well-defined edges of a balloon image, and the total radiopacity of the balloon does not change as the balloon is inflated. Also, a method of imaging a balloon wall and a method of imaging a radiopaque adhesive between two layers of a balloon wall are provided.Type: GrantFiled: September 22, 2020Date of Patent: May 14, 2024Assignee: C.R. Bard, Inc.Inventor: Richard K. Elton
-
Patent number: 11969579Abstract: A method of insulin delivery, the method may include obtaining one or more blood glucose readings of a user, and, based on the blood glucose readings, generating a set of insulin delivery actions that may include delivery of a baseline basal rate or predefined variations of the baseline basal rate. The method may also include monitoring previous insulin delivery actions to the user to determine whether the previous insulin delivery actions include insulin beyond a threshold amount, where the previous insulin delivery actions may include delivery of the baseline basal rate or predefined variations of the baseline basal rate, and, based on the previous insulin delivery actions including insulin beyond the threshold amount, adjusting the set of insulin delivery actions.Type: GrantFiled: June 11, 2021Date of Patent: April 30, 2024Assignee: Insulet CorporationInventors: Bryan Mazlish, Lane Desborough
-
Patent number: 11957876Abstract: An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.Type: GrantFiled: March 25, 2021Date of Patent: April 16, 2024Assignee: BETA BIONICS, INC.Inventors: Edward B. Raskin, David Chi-Wai Lim, Michael J. Rosinko, Firas H. El-Khatib, Edward R. Damiano
-
Patent number: 11957875Abstract: Disclosed are a device, system, methods and computer-readable medium products that provide an updated insulin-to-carbohydrate ratio and an updated total daily insulin. The described processes may be used for periodic updating of the insulin-to-carbohydrate ratio and the total daily insulin. The insulin-to-carbohydrate ratio and/or the total may be used in the calculation of new doses of insulin that a drug delivery device may be commanded to deliver to a user.Type: GrantFiled: December 4, 2020Date of Patent: April 16, 2024Assignee: INSULET CORPORATIONInventors: Yibin Zheng, Joon Bok Lee, Steven Cardinali, Jason O'Connor, Eric Benjamin, Ian McLaughlin, David Nazzaro, Ashutosh Zade
-
Patent number: 11957874Abstract: Some embodiments an infusion pump system can be configured to modify alarm limit parameters as the user's insulin load increases or decreases. Moreover, in particular embodiments, the infusion pump system can be configured to provide a “missed bolus” or “missed meal” alarm in response to the user's blood glucose characteristics, the user's insulin load information, or the like.Type: GrantFiled: July 14, 2020Date of Patent: April 16, 2024Assignee: INSULET CORPORATIONInventor: Mark C. Estes
-
Patent number: 11951246Abstract: A method of coaching a patient to use an inhaler for medication delivery is provided. The method includes obtaining, via a sensor, respiratory behavior data of the patient; receiving, at a computing device, the respiratory behavior data; performing a respiratory pattern analysis algorithm on the respiratory behavior data to determine a desired interval of inhaler actuation for medication delivery; communicating a cue signal to actuate the inhaler to achieve the desired interval; obtaining, via the sensor, inhaler actuation data based on the actuation of the inhaler; receiving, at the computing device, the inhaler actuation data; performing an actuation analysis algorithm on the inhaler actuation data to assess the efficacy of the actuation; and adjusting the cue signal to actuate the inhaler to improve the efficacy of a future actuation.Type: GrantFiled: September 27, 2023Date of Patent: April 9, 2024Assignee: Yale UniversityInventor: Peter Kahn
-
Patent number: 11951262Abstract: Catheters, sheaths, or other tubular devices are provided that include a proximal end, a distal end sized for introduction into a patient's body, and a steerable distal portion. The tubular device includes a primary lumen extending between the proximal and distal ends; an auxiliary lumen adjacent the primary lumen; and one or more reinforcement members including windings extending helically along at least the distal portion, at least some of the windings passing between the primary and steering element lumens and at least some of the windings surrounding both the primary and steering element lumens. In one embodiment, a steering element is slidably disposed within the auxiliary lumen. Apparatus and methods for making such tubular devices are also provided.Type: GrantFiled: March 15, 2021Date of Patent: April 9, 2024Assignee: CLPH, LLCInventors: Stephen A. Leeflang, Christian S. Eversull
-
Patent number: 11944400Abstract: Robotic Angioplasty and Endoluminar Surgery System to separate patient and operator by remotely moving guides and catheters during operations, composed of three or more elements, of which at least one disposable (nose), available in different versions, like for independent advancements and retractions of a balloon catheter (or stent) and relative guide and to their common axial rotation, or for moving a guide with a moving core or a catheter. The nose should be inserted into a non-sterile Slave placed near the patient, covered with sterile drapes, and with a combination of toothed wheels it translates all into three rotations controlled by three independent motors, possibly measuring the torque applied by the motors. By replacing the three angular gauges to the motors, a Master is obtained, controlled by a doctor by moving non-sterile tubes.Type: GrantFiled: October 26, 2018Date of Patent: April 2, 2024Inventors: Guido Danieli, Ciro Indolfi, Salvatore De Rosa, Domenico Battaglia, Giovanni De Gaetano, Gionata Fragomeni, Pasquale Francesco Greco, Gabriele Larocca, Michele Perrelli
-
Patent number: 11944771Abstract: The invention claims a new type of handheld medical device is meant to help the medical community by enabling them to treat patients remotely. This solves the problem of patient suffering or death due to lack of access to a medical professional or long wait times by enabling a patient-centred response to diseases, such as COVID-19. The device is hand-held, with incorporated germicidal UVC lights, an internal application tip and the delivery mechanism focuses on the mucous membrane. The top chamber connects to a removable container which can be used with the prescribed treatment/therapy, vaccine, or viral testing fluid/reagent, as needed. The versatility, non-invasive nature and germicidal properties constitute distinct improvements over other similar medical devices. This device also promotes the development of non-invasive inoculation and drug delivery systems via the mucous membrane.Type: GrantFiled: March 9, 2022Date of Patent: April 2, 2024Inventor: Andrada Bucataru
-
Patent number: 11944785Abstract: Devices, systems, and techniques for therapy delivery and healthcare management is described. In one example, a system comprises a delivery device configured to execute therapy information comprising a treatment schedule specifying one or more treatments over a time period, wherein for each of the one or more treatments, the therapy information comprises a treatment type and a treatment amount; and processing circuitry configured to: determine a modification to the therapy information based on a recommendation of a digital twin, wherein the digital twin determines an estimated glucose level expected to be within a healthy range if the delivery device executes the modification to therapy information; and in response to physician review of the modification to the therapy information, output, to a healthcare provider system for the patient, data indicating completion of a healthcare service corresponding to the physician review.Type: GrantFiled: December 4, 2020Date of Patent: April 2, 2024Assignee: Medtronic MiniMed, Inc.Inventors: Louis J. Lintereur, Catherine Tan Fogel, Patrick E. Weydt, Benyamin Grosman, Mahta Sadeghzadeh
-
Patent number: 11944178Abstract: A system and method for dermal spraying includes a portable, hand-held dermal application device with disposable formulation capsules that spray a formulation unto the skin and a data transmission unit operatively connecting the dermal spray device to a mobile device. The mobile device communicates with a remote server and transmits anonymized data about the user's skin conditions and treatment history. The anonymized data may be labelled and classified by a dermatologist, and stored on a secure cloud server. The anonymized data is used to train models for serum and treatment plan recommenders.Type: GrantFiled: April 7, 2021Date of Patent: April 2, 2024Assignee: Kozhya LLC SP Z.O.O.Inventors: Yoanna Gouchtchina, Enrique Gallar
-
Patent number: 11938260Abstract: An apparatus for guiding cannulation with a dialysis needle of an arteriovenous dialysis access graft subcutaneously implanted in a body of a subject. The guiding apparatus comprises an elongated body member comprising a base portion terminating in longitudinal edges, a distance between the longitudinal edges of the base portion being substantially equal to a lateral dimension of the aces graft, and an elongated tubular sleeve defining an pocket having a longitudinal dimension and a lateral dimension configured to receive the body member. The body member is adapted to be received in the pocket of the sleeve for securing adjacent the subcutaneous access graft such that the inner surface of the base portion is aligned with a cannulation point of the graft for guiding location of a needle insertion.Type: GrantFiled: July 19, 2021Date of Patent: March 26, 2024Assignee: InnAVasc Medical, Inc.Inventors: Shawn M. Gage, Jeffrey H. Lawson, Joseph Knight, Craig Nichols
-
Patent number: 11938302Abstract: An insulin patch control method and a device therefor are provided. An insulin patch control method and a device therefor are provided. The insulin patch control method according to one embodiment of the present invention comprises the steps of: obtaining, from an insulin patch, blood glucose information measured by a blood glucose sensor; inputting the obtained blood glucose information into a first neural network; estimating a pump parameter of the insulin patch on the basis of output data of the first neural network; and simulating the insulin patch by inputting the blood sugar information and the pump parameter into a second neural network.Type: GrantFiled: October 14, 2021Date of Patent: March 26, 2024Assignee: EOFLOW CO., LTD.Inventors: Ian G. Welsford, Inwook Bin, Ho Min Jeon
-
Patent number: 11942202Abstract: Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.Type: GrantFiled: August 16, 2021Date of Patent: March 26, 2024Assignee: Nudge BG, Inc.Inventor: Lane Desborough
-
Patent number: 11925788Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.Type: GrantFiled: March 2, 2022Date of Patent: March 12, 2024Assignee: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Firas H. El-Khatib, Himanshu Patel